What is NYC's health score?

American Strategic Investment Co. (NYC) has a TradeApes health score of 47 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NYC's estimated fair value?

Based on our 5-year discounted cash flow model, American Strategic Investment Co.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NYC undervalued or overvalued?

Our model currently rates NYC as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NYC... Refresh in a moment for the full analysis.

American Strategic Investment Co. (NYC)

Real Estate Inconclusive inconclusive mixed

$8.68

Updated: 2026-06-02

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

40 Weak

Relative Value

30 Weak

Capital Allocation

45 Mixed

Risk

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.